Thermo Fisher gets EU approval for $3.5B Phadia acquisition

08/29/2011 | MassDevice.com (Boston)

Thermo Fisher Scientific's purchase of Phadia, a maker of blood tests in Sweden, for $3.5 billion has received the green light from the European Commission. The transaction, which offers Thermo Fisher a broader footprint in specialty diagnostics, "would not raise competition concerns," the Commission said in a release.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ